Hemostatic Profiles of Endocrine Therapies for Breast Cancer

The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins

NCT01341171 ·Status: COMPLETED

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

NCT00253539 ·Status: COMPLETED ·Phase: PHASE2

Coagulation Parameters in Postmenopausal Breast Cancer Patients Under Adjuvant Hormonal Therapy

NCT00814034 ·Status: COMPLETED

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

NCT00903162 ·Status: COMPLETED ·Phase: PHASE2

Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

NCT00569543 ·Status: COMPLETED

The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer

NCT00830973 ·Status: COMPLETED

Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer

NCT06781762 ·Status: RECRUITING

Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane

NCT00291798 ·Status: COMPLETED ·Phase: PHASE2

Fertility Preservation in Breast Cancer Patients

NCT02661932 ·Status: COMPLETED ·Phase: PHASE4

Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients

NCT01155063 ·Status: TERMINATED

Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up

NCT01357772 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

NCT04666805 ·Status: UNKNOWN

Letrozole, Anastrozole, Exemestane, or Tamoxifen Citrate in Treating Postmenopausal Women With Breast Cancer

NCT00893061 ·Status: COMPLETED ·Phase: PHASE3

Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients

NCT00309491 ·Status: COMPLETED ·Phase: PHASE3

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

NCT00066690 ·Status: COMPLETED ·Phase: PHASE3

Musculoskeletal Pain in Postmenopausal, Early Breast Cancer Patients Receiving Aromatase Inhibitor Therapy - A Pilot Study

NCT00653718 ·Status: COMPLETED

Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer

NCT00884143 ·Status: COMPLETED

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3

Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women

NCT00237133 ·Status: COMPLETED ·Phase: PHASE4

Letrozole in Preventing Breast Cancer in Postmenopausal Women

NCT00090857 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer

NCT00330317 ·Status: COMPLETED ·Phase: PHASE3

Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer

NCT00002646 ·Status: COMPLETED ·Phase: PHASE3

Pharmacology of Adjuvant Hormonotherapy in Breast Cancer

NCT01127295 ·Status: COMPLETED ·Phase: PHASE4

Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer

NCT01077453 ·Status: COMPLETED ·Phase: PHASE1

Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer

NCT01781338 ·Status: COMPLETED ·Phase: PHASE2/PHASE3